Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.

Share this video  

EORTC CLTF 2021 | The diagnostic work-up of CBCL in Sweden

Amra Osmancevic • 15 Oct 2021
EORTC CLTF 2021
B-Cell Lymphoma Cutaneous B-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases

Amra Osmancevic, MD, PhD, University of Gothenburg, Gothenburg, Sweden, gives an overview of the diagnostic work-up of cutaneous B-cell lymphoma (CBCL) in Sweden, commenting on the role of national multidisciplinary teams. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Amra Osmancevic

Patient selection for CTCL 0:32
Patient selection for CTCL
Amra Osmancevic • 15 Oct 2021
Diagnostics and treatment outcomes from primary CBCL 1:22
Diagnostics and treatment outcomes from primary CBCL
Amra Osmancevic • 15 Oct 2021
Classifying CBCL subtypes 0:43
Classifying CBCL subtypes
Amra Osmancevic • 15 Oct 2021
The importance of the EORTC CL meeting 0:47
The importance of the EORTC CL meeting
Amra Osmancevic • 15 Oct 2021

Related Videos

Long-term follow-up results from ELM-2: odronextamab in R/R FL 8:08
Long-term follow-up results from ELM-2: odronextamab in R/R FL
Gottfried von Keudell • 18 Sep 2025
The efficacy of glofitamab in patients with heavily pre-treated R/R MCL 1:24
The efficacy of glofitamab in patients with heavily pre-treated R/R MCL
Tycel Phillips • 5 Sep 2025
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute 1:01
Bringing clinical trials to the community: current approaches at Sarah Cannon Research Institute
Krish Patel • 4 Sep 2025
Bispecifics and CAR T-cell therapy in lymphoma: sequencing strategies and considerations 1:52
Bispecifics and CAR T-cell therapy in lymphoma: sequencing strategies and considerations
Tycel Phillips • 5 Sep 2025
The content of VJHemOnc is intended for healthcare professionals